Japanese Company Says ‘Yes,’ While NHTSA ‘Continues To Examine the New Batch’ The jury is out on whether Takata’s replacement airbag systems are safer than the 17 million recalled for dangerously exploding inside the vehicle upon deployment. The Japanese company that dominates the airbag market says the replacements are safe, […]

The news about cyberbullying – a terrible trend involving online abuse between children, teens and young adults – just got worse. A study by McAfee, an Internet security company owned by Intel, reports cyberbullying incidents tripled in 2014. “Alarmingly…a whopping 87% have witnessed cyberbullying and 26% have been victims themselves,” […]

Two disturbing cases for different, but similar reasons. When did parties jump from collection and culling of documents to simply turning over all possible evidence blindly and relying on a claw back agreement to protect the producing party? Putting aside that works entirely in favor of the receiving party, this […]

Information is the cornerstone to modern, 21st century society. Transparency and information gives citizens and consumers the power to make informed decisions on who to vote for or which products to consume. Backroom deals, nepotism and corruption operate in the shade of misinformation, disinformation, and unknowable and incomprehensible processes and […]

On July 11, 2014, Judge Joseph R. Goodwin of the United States District Court for the Southern District of West Virginia, ruled that a lawsuit filed against Boston Scientific in connection with its Obtryx transvaginal mesh device was time barred under Massachusetts’ three year statute of limitations because the plaintiff […]

Invent something, patent it and watch your creative enterprise grow into an empire. That’s what inventors are supposed to do. Some of them still follow the rules. Others do not. Among the more unscrupulous are so-called patent trolls who search the market looking for products over which they can sue. […]

Merck announced on June 4, 2014, that it would be funding the $100 million dollar NuvaRing settlement announced in February of this year, as the 95% plaintiff participation threshold required by the Settlement Agreement has been reached. The $100 million settlement will resolve several thousand individual lawsuits that were filed […]

A major move toward public safety may be one step closer with the U.S. Food and Drug Administration announcing this week that it will put a proposal out for public comment that would reclassify pelvic organ prolapse (POP) mesh from moderate to high risk. If approved, that move would require […]

In any document search allowing defendants’ custodians to conduct their own searches is much like allowing the fox to guard the henhouse. Even focused and disciplined custodial collections can be fraught with problems. Example Email sent during product development: “ Jim – I am writing to you because of the […]

Doctors and physicians are given a great deal of discretion when it comes to prescribing drugs for uses other than those indicated by the FDA. This is known as “off-label” use. The FDA, realizing the danger of off-label promotion in its 2009 guidance, has set forth rules to restrict the […]